Please use this identifier to cite or link to this item:
Author(s): Freitas, AT
Calhau, C
Antunes, G
Araújo, B
Bandeira, M
Barreira, S
Bazenga, F
Braz, S
Caldeira, D
Santos, SCR
Faria, A
Faria, D
Fraga, M
Nogueira-Garcia, B
Gonçalves, L
Kovalchuk, P
Lacerda L
Lopes, H
Luís, D
Medeiros, F
Melo, AMP
Melo-Cristino, J
Miranda, A
Pereira, C
Pinto, AT
Pinto, J
Proença, H
Ramos, A
Rato, JPR
Rocha, F
Rocha, JC
Moreira-Rosário, A
Vazão, H
Volovetska, Y
Guimarães, JT
Pinto, FJ
Title: Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
Publisher: Nature Research
Issue Date: 2021
Abstract: Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.
Subject: Immunogenetics
Predictive markers
Risk factors
Viral infection
Source: Sci Rep. 2021 Oct 21;11(1):20837
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
Appears in Collections:ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
freitas-sr-2021.pdf1.9 MBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons